PPARGC1A and renal cell carcinoma: Inhibition of TGF-β signaling utilizing multiple inhibitors (SB431542, LY2109761, and LY364947) resulted in an increase of PPARGC1A transcript levels in RCC cells (Figure 4A and Supplemental Figure 3D).